Home  »  Hot Stocks   »  Looking Closely at the Growth Curve for Precigen I...

Looking Closely at the Growth Curve for Precigen Inc. (PGEN)

Precigen Inc. (NASDAQ:PGEN) went down by -13.81% from its latest closing price compared to the recent 1-year high of $5.65. The company’s stock price has collected -16.30% of loss in the last five trading sessions.

Is It Worth Investing in Precigen Inc. (NASDAQ :PGEN) Right Now?

Plus, the 36-month beta value for PGEN is at 2.05.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


The average price from analysts is $12.75, which is $10.44 above the current price. PGEN currently public float of 183.42M and currently shorts hold a 5.67% ratio of that float. Today, the average trading volume of PGEN was 1.57M shares.

PGEN’s Market Performance

PGEN stocks went down by -16.30% for the week, with a monthly jump of 12.68% and a quarterly performance of 79.07%, while its annual performance rate touched -57.46%. The volatility ratio for the week stands at 10.52% while the volatility levels for the past 30 days are set at 8.49% for Precigen Inc. The simple moving average for the period of the last 20 days is -6.93% for PGEN stocks with a simple moving average of 5.60% for the last 200 days.

Analysts’ Opinion of PGEN

Many brokerage firms have already submitted their reports for PGEN stocks, with Stifel repeating the rating for PGEN by listing it as a “Buy.” The predicted price for PGEN in the upcoming period, according to Stifel is $13 based on the research report published on February 25th of the previous year 2021.

Wells Fargo, on the other hand, stated in their research note that they expect to see PGEN reach a price target of $14. The rating they have provided for PGEN stocks is “Overweight” according to the report published on February 22nd, 2021.

B. Riley Securities gave a rating of “Buy” to PGEN, setting the target price at $10 in the report published on February 18th of the previous year.

PGEN Trading at 6.57% from the 50-Day Moving Average

After a stumble in the market that brought PGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -59.13% of loss for the given period.

Volatility was left at 8.49%, however, over the last 30 days, the volatility rate increased by 10.52%, as shares surge +8.96% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +44.37% upper at present.

During the last 5 trading sessions, PGEN fell by -16.30%, which changed the moving average for the period of 200-days by -37.06% in comparison to the 20-day moving average, which settled at $2.49. In addition, Precigen Inc. saw -37.74% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at PGEN starting from Thomasian Harry Jr., who purchase 24,500 shares at the price of $2.09 back on Aug 23. After this action, Thomasian Harry Jr. now owns 56,390 shares of Precigen Inc., valued at $51,205 using the latest closing price.

KINDLER JEFFREY B, the Director of Precigen Inc., sale 50,000 shares at $2.30 during a trade that took place back on Aug 11, which means that KINDLER JEFFREY B is holding 214,411 shares at $115,000 based on the most recent closing price.

Stock Fundamentals for PGEN

Equity return is now at value -99.60, with -26.30 for asset returns.

Is Cadence Bank (CADE) a Keeper?

Cadence Bank (NYSE:CADE) went down by -0.52% from its latest closing price compared to the recent 1-year high of $34.24. The company’s stock price has